Type I Gonadotropin-Releasing Hormone Receptor Mediates the Antiproliferative Effects of GnRH-II on Prostate Cancer cells
Articolo
Data di Pubblicazione:
2009
Citazione:
Type I Gonadotropin-Releasing Hormone Receptor Mediates the Antiproliferative Effects of GnRH-II on Prostate Cancer cells / M. Montagnani Marelli, R.M. Moretti, S. Mai, J. Januszkiwicz-Caulier, M. Motta, P. Limonta. - In: THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM. - ISSN 0021-972X. - 94:5(2009 May), pp. 1761-1767. [10.1210/jc.2008-1741]
Abstract:
Background: GnRH-II has been shown to exert a strong antiproliferative action on tumors of the
female reproductive system. The data so far reported on the effects of GnRH-II on prostate cancer
growth are controversial. Moreover, it is still unclear through which receptor [type I or type II
GnRH-receptor (GnRH-R)] GnRH-II might modulate cancer cell proliferation.
Objective: The objective of this work was to investigate whether GnRH-II might affect the proliferation
of prostate cancer cells and to identify the GnRH-R through which the peptide might exert
its activity.
Design: We investigated the effects of GnRH-II on prostate cancer cell proliferation. We then
transfected PC3 cells with a small interfering RNA targeted to type I GnRH-R. After receptor silencing
we evaluated the effects of GnRH-II on cell proliferation and on forskolin-induced intracellular
cAMP accumulation. Similar experiments were performed by silencing type II GnRH-R.
Results: GnRH-II exerted an antiproliferative activity on prostate cancer cells. Transfection of PC3
cells with a type I GnRH-R small interfering RNA resulted in a significant decrease of the expression
of this receptor. After type I GnRH-R silencing: 1) the antiproliferative effect of GnRH-II was completely
abrogated; and 2) GnRH-II lost its capacity to counteract the forskolin-induced cAMP accumulation.
On the contrary, type II GnRH-R silencing did not counteract the antiproliferative
effect of GnRH-II.
Conclusions: GnRH-II exerts a specific and significant antiproliferative action on prostate cancer
cells. This antitumor effect is mediated by the activation of type I (but not of type II) GnRH-R and
by its coupled cAMP intracellular signaling pathway. (J Clin Endocrinol Metab 94: 1761–1767, 2009)
Tipologia IRIS:
01 - Articolo su periodico
Elenco autori:
M. Montagnani Marelli, R.M. Moretti, S. Mai, J. Januszkiwicz Caulier, M. Motta, P. Limonta
Link alla scheda completa:
Link al Full Text: